← Open Payments lookup

SHARON SWEETEN: Open Payments

NPI 1841630969 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,769 in 49 payments from 19 companies in 2025. Trend: 2023 $1,767 · 2024 $1,127 · 2025 $1,769

Food & beverage: $1,769
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation10$193
Actelion Pharmaceuticals US, Inc.3$181
Amgen Inc.5$180
Novo Nordisk Inc4$175
SCPHARMACEUTICALS INC.3$149
ABIOMED1$126
Corcept Therapeutics1$123
Alnylam Pharmaceuticals Inc.1$122
VERTEX PHARMACEUTICALS INCORPORATED1$96
Merck Sharp & Dohme LLC5$88

Products named: LEQVIO, REPATHA, FUROSCIX, Ozempic, Korlym, AMVUTTRA, UPTRAVI, JOURNAVX.

Industry payments across TX — which companies pay providers there.